Prime Minister Narendra Modi on Monday held a virtual meeting with three teams working on developing and manufacturing COVID-19 vaccine, and said they should take extra efforts to inform people in simple language about the vaccine and related matters such as its efficacy.
A statement from the Prime Minister's Office said that Modi also asked the companies, represented by these teams, to come out with their suggestions and ideas regarding the regulatory processes and related matters.
"The PM advised all the departments concerned to engage with the manufacturers and seek to resolve matters so that the efforts by these companies bear fruit in order to serve the needs of the country and the entire world," it added.
These teams were from Gennova Biopharmaceuticals Ltd Pune, Biological E Ltd Hyderabad and Dr Reddys Laboratories Ltd Hyderabad.
The prime minister appreciated the efforts being taken by scientists in these companies to come out with a vaccine solution to tackle COVID-19.
The potential of various platforms for vaccine development was also discussed, the statement said.
Matters relating to logistics, transport, cold chain etc in respect of delivering the vaccines were also discussed.
All the vaccine candidates discussed are at different stages of trials and detailed data and results are expected early next year onwards, it added.
Modi had on Saturday visited Ahmedabad, Hyderabad and Pune to review the development and manufacturing process of coronavirus vaccines at facilities in these cities.
The total coronavirus cases in India have mounted to 94,31,691 with 38,772 new infections, while the death toll climbed to 1,37,139 after 443 more fatalities were reported, according to Health Ministry data.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU